tiprankstipranks
Trending News
More News >
XBiotech Inc. (DE:4XB)
:4XB
Germany Market
Advertisement

XBiotech (4XB) Stock News & Sentiment

Compare
0 Followers
XBiotech’s New Trial: A Potential Game-Changer for Rheumatoid Arthritis Treatment?
Premium
Company Announcements
XBiotech’s New Trial: A Potential Game-Changer for Rheumatoid Arthritis Treatment?
16d ago
XBiotech Signs New Executive Agreement with CEO
Premium
Company Announcements
XBiotech Signs New Executive Agreement with CEO
1M ago
XBiotech Holds Annual Stockholders Meeting on August 29
Premium
Company Announcements
XBiotech Holds Annual Stockholders Meeting on August 29
2M ago

4XB News on the Web

News Score - Last 7 Days

Neutral
DE:4XB
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:4XB’s Media Buzz Sentiment?
2 articles about DE:4XB were published this week. In an average week, 1 articles are published.
    What is DE:4XB’s weekly average amount of articles?
    In an average week, 1 articles about DE:4XB are published.
      What is DE:4XB’s News Sentiment?
      50% of articles about DE:4XB were positive this week, compared to its sector average of 54%.
        Healthcare Stocks that are Trending in the News
        CVKDCadrenal Therapeutics, Inc.
        CNMDConmed
        ALKSAlkermes
        AMNAMN Healthcare Services
        HAEHaemonetics
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis